These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 17910812)
1. Is bicarbonate buffer suitable as a dissolution medium? Boni JE; Brickl RS; Dressman J J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812 [TBL] [Abstract][Full Text] [Related]
2. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. Fadda HM; Merchant HA; Arafat BT; Basit AW Int J Pharm; 2009 Dec; 382(1-2):56-60. PubMed ID: 19666093 [TBL] [Abstract][Full Text] [Related]
3. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs. McNamara DP; Whitney KM; Goss SL Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520 [TBL] [Abstract][Full Text] [Related]
4. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer. Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131 [TBL] [Abstract][Full Text] [Related]
5. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer. Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364 [TBL] [Abstract][Full Text] [Related]
6. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647 [TBL] [Abstract][Full Text] [Related]
7. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer. Liu F; Shokrollahi H Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736 [TBL] [Abstract][Full Text] [Related]
8. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. Vertzoni M; Fotaki N; Kostewicz E; Stippler E; Leuner C; Nicolaides E; Dressman J; Reppas C J Pharm Pharmacol; 2004 Apr; 56(4):453-62. PubMed ID: 15099440 [TBL] [Abstract][Full Text] [Related]
9. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer. Okamoto N; Higashino M; Yamamoto H; Sugano K Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942 [TBL] [Abstract][Full Text] [Related]
10. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Sheng JJ; McNamara DP; Amidon GL Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104 [TBL] [Abstract][Full Text] [Related]
11. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles. Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282 [TBL] [Abstract][Full Text] [Related]
12. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release. Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141 [TBL] [Abstract][Full Text] [Related]
13. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers. Sakamoto A; Sugano K Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285 [TBL] [Abstract][Full Text] [Related]
14. Biorelevant dissolution media as a predictive tool for glyburide a class II drug. Wei H; Löbenberg R Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694 [TBL] [Abstract][Full Text] [Related]
15. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865 [TBL] [Abstract][Full Text] [Related]
16. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets. Shibata H; Yoshida H; Izutsu K; Goda Y J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275 [TBL] [Abstract][Full Text] [Related]
17. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates. Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603 [TBL] [Abstract][Full Text] [Related]
18. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases. Krieg BJ; Taghavi SM; Amidon GL; Amidon GE J Pharm Sci; 2015 Sep; 104(9):2894-904. PubMed ID: 25980464 [TBL] [Abstract][Full Text] [Related]
19. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers. Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674 [TBL] [Abstract][Full Text] [Related]
20. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media. Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]